Determining Linezolid’s Baseline In Vitro Activity in Canada Using Gram-Positive Clinical Isolates Collected prior to Its National Release

Documenti analoghi

• Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001
  di: Critchley, Ian A., et al.
  Pubblicazione: (2003)
• Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance
  di: Sahm, Daniel F., et al.
  Pubblicazione: (2001)
• In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
  di: Wenzel, Richard P., et al.
  Pubblicazione: (2003)
• Need for Annual Surveillance of Antimicrobial Resistance in Streptococcus pneumoniae in the United States: 2-Year Longitudinal Analysis
  di: Sahm, Daniel F., et al.
  Pubblicazione: (2001)
• Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States
  di: Karlowsky, James A., et al.
  Pubblicazione: (2002)